SCHEMBL6174783

SCHEMBL6174783

CC(C)(C)[Si](C)(C)OCCc1ccc(-n2cc(-c3ccccc3)nc2-c2ccccc2)cc1

nearest known ligand 0.44

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 3/20 0.44
PTGS1 P23219 2/20 0.42
SMN1; SMN2 Q16637 3/20 0.38
GABRA2 P47869 3/20 0.38
GABRB2 P47870 3/20 0.38
NPC1 O15118 3/20 0.38
RAB9A P51151 3/20 0.38
MAPT P10636 2/20 0.38
LMNA P02545 2/20 0.38
HSD11B1 P28845 2/20 0.36
TP53 P04637 1/20 0.34
THRB P10828 1/20 0.34
GPR119 Q8TDV5 1/20 0.33
MEN1 O00255 1/20 0.33
ALDH1A1 P00352 1/20 0.33
GAA P10253 1/20 0.33
HTT P42858 1/20 0.33
KMT2A Q03164 1/20 0.33
TDP1 Q9NUW8 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6176741 0.91 GPR119 (0.41) PTGS2PTGS1SMN1; SMN2GABRA2GABRB2
SCHEMBL6179637 0.89 SMN1; SMN2 (0.37) PTGS2SMN1; SMN2GABRA2GABRB2NPC1
SCHEMBL6329377 0.89 SMN1; SMN2 (0.38) PTGS2SMN1; SMN2NPC1RAB9AMAPT
SCHEMBL6179907 0.84 LMNA (0.36) PTGS2SMN1; SMN2NPC1RAB9AMAPT
SCHEMBL6253206 0.84 AGER (0.46) SMN1; SMN2NPC1RAB9AMAPTLMNA
SCHEMBL6178027 0.78 NPC1 (0.50) NPC1RAB9AGPR119
SCHEMBL6175631 0.76 PTGS1 (0.55) PTGS2PTGS1SMN1; SMN2GABRA2GABRB2
SCHEMBL9185281 0.74 IDO1 (0.42) SMN1; SMN2NPC1RAB9AMEN1ALDH1A1
SCHEMBL6175669 0.73 PTGS1 (0.54) PTGS2PTGS1SMN1; SMN2GABRA2GABRB2
SCHEMBL28111728 0.73 PTGS1 (0.54) PTGS2PTGS1SMN1; SMN2GABRA2GABRB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6956050-B2 Imidazole compounds as anti-inflammatory and analgesic agents PFIZER, INC. (US) 2005-10-18 US disclosed
EP-1494667-A1 IMIDAZOLE COMPOUNDS AS ANTI-INFLAMMATORY AND ANALGESIC AGENTS Pfizer Japan Inc. (JP) 2005-01-12 EP disclosed
US-20030220372-A1 Imidazole compounds as anti-inflammatory and analgesic agents HIRANO MISATO (JP) 2003-11-27 US disclosed
WO-2003086390-A1 IMIDAZOLE COMPOUNDS AS ANTI-INFLAMMATORY AND ANALGESIC AGENTS PFIZER JAPAN INC. (JP) 2003-10-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030220372-A1 Imidazole compounds as anti-inflammatory and analgesic agents PTGS1, PTGS2, PTGES PTGS2 2/4885PTGS1 1/4885SMN1; SMN2 4565/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.